Cardiac markers: present and future

[1]  R. Hooper.  Book Review: Pathology & Laboratory Medicine: Cardiac Markers , 1999 .

[2]  M Zaninotto,et al.  Strategies for the early diagnosis of acute myocardial infarction using biochemical markers. , 1999, American journal of clinical pathology.

[3]  H Jick,et al.  Antibiotics and risk of subsequent first-time acute myocardial infarction. , 1999, JAMA.

[4]  E. Lander,et al.  Effects of Medical Research on Health Care and the Economy , 1999, Science.

[5]  E. Braunwald.  Evolution of the management of acute myocardial infarction: a 20th century saga , 1998, The Lancet.

[6]  C. Hamm.  Progress in the diagnosis of unstable angina and perspectives for treatment. , 1998, European heart journal.

[7]  D. Levy,et al.  Death rates from coronary disease--progress and a puzzling paradox. , 1998, The New England journal of medicine.

[8]  A. Folsom,et al.  Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. , 1998, The New England journal of medicine.

[9]  J. Liao,et al.  Endothelium and acute coronary syndromes. , 1998, Clinical chemistry.

[10]  D. Hoppensteadt,et al.  Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. , 1998, Clinical chemistry.

[11]  R. Cannon.  Role of nitric oxide in cardiovascular disease: focus on the endothelium. , 1998, Clinical chemistry.

[12]  R J Glynn,et al.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. , 1998, Circulation.

[13]  M. Plebani,et al.  Diagnostic strategies using myoglobin measurement in myocardial infarction. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[14]  R. Jansen,et al.  Additional Essential Criteria for Quality Systems of Medical Laboratories , 1998, Clinical chemistry and laboratory medicine.

[15]  H. Katus,et al.  Myocardial Damage: The role of Troponin T , 1998 .

[16]  M. Panteghini,et al.  Troponin I: Structure, Physiology and It’s Role in Risk Stratification of Angina Patients , 1998 .

[17]  M. Plebani,et al.  Diagnostic strategies in myocardial infarction using myoglobin measurement. , 1998, European heart journal.

[18]  P. Libby,et al.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. , 1997, Circulation.

[19]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[20]  A. Wu.  Use of cardiac markers as assessed by outcomes analysis. , 1997, Clinical biochemistry.

[21]  Stgrp Capture,et al.  Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study , 1997, The Lancet.

[22]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[23]  M. Plebani,et al.  Carboxypeptidase N and Creatine Kinase-MB Isoforms in Acute Myocardial Infarction , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[24]  M. Plebani,et al.  Fluoroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction. , 1996, Clinical chemistry.

[25]  D G Carville,et al.  Thrombus precursor protein (TpP): marker of thrombosis early in the pathogenesis of myocardial infarction. , 1996, Clinical chemistry.

[26]  H. Väänänen,et al.  Myoglobin/carbonic anhydrase III ratio: highly specific and sensitive early indicator for myocardial damage in acute myocardial infarction. , 1996, Clinical chemistry.

[27]  J. Maessen,et al.  Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. , 1995, Circulation.

[28]  J. Mair,et al.  Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. , 1995, Clinical chemistry.

[29]  U. Hofmann,et al.  Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. , 1995, Clinical chemistry.

[30]  M. Plebani,et al.  Evaluation of a new automated system for the determination of ck‐mb isoforms , 1995, Journal of clinical laboratory analysis.

[31]  P. Ridker,et al.  Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. , 1994, Circulation.

[32]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[33]  L. Wilkins.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .

[34]  V. Ploplis,et al.  A monoclonal antibody which recognises an epitopic region unique to the intact fibrin polymeric structure , 1993 .

[35]  G. Jablonsky,et al.  Diagnostic evaluation of creatine kinase-2 mass and creatine kinase-3 and -2 isoform ratios in early diagnosis of acute myocardial infarction. , 1993, Clinical chemistry.

[36]  Burton A. Weisbrod,et al.  The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment , 1991 .

[37]  J. Loscalzo,et al.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. , 1990, The Journal of clinical investigation.

[38]  E F Cook,et al.  Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. , 1987, Annals of internal medicine.

[39]  L. Thomas.  The Lives of a Cell , 1974 .

[40]  W. Kannel,et al.  Cigarette Smoking and Coronary Heart Disease , 1962 .

[41]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.